Wir sind mit live! Mehr erfahren

Cypherpunk Technologies Inc

CYPH

Börsenwert 277 Mio. $

2,57 USD

-0,45

14,9 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

2,60

+0,03

1,17 %

1 Tag

-14,9 %

5 Tage

-14,62 %

1 Monat

5,33 %

3 Monate

260,7 %

6 Monate

186,19 %

Seit Jahresbeginn

127,43 %

1 Jahr

348,59 %

5 Jahre

-91,23 %

10 Jahre

-96,73 %

Profil: Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Mitarbeiter: 6

Finanzwesen Vermögensverwaltung

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 20 %

Neutral 80 %

Negativ 0 %

Cypherpunk Technologies Appoints Amanda Fabiano to Board of Directors

Veteran mining executive brings operational depth from Nakamoto, TeraWulf, Galaxy, and Fidelity as Cypherpunk launches 4.2 GSol/s Zcash mining fleet Cypherpunk Mining generated 3,023.13 ZEC in first weeks of operation; Added to Treasury CAMBRIDGE, Mass., Sept. 22, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), a privacy technology company, today announced the appointment of Amanda Fabiano to its Board of Directors.

Cypherpunk Technologies Appoints Amanda Fabiano to Board of Directors

Cypherpunk Technologies Looks Fully Valued After Zcash-Fueled Surge

Cypherpunk Technologies Inc. now holds a significant ZEC treasury and has acquired a major Zcash mining operation, boosting its asset value. Recent ZEC price surges and the launch of the Zcash ETF have driven CYPH's valuation, but the stock's rapid rise has consumed much of its immediate upside. CYPH's fully diluted share count and complex capital structure mean headline market cap underestimates the price investors are paying for exposure.

Cypherpunk Technologies Looks Fully Valued After Zcash-Fueled Surge

Cypherpunk Technologies Launches World's Largest Zcash Mining Fleet

Equity-based transaction with Winklevoss Capital activates 4.2 GSol/s of live, U.S.-based hashrate; approximately 18% of the Zcash network; Industry veteran Kevin Zhang joins as Head of Mining CAMBRIDGE, Mass., Aug. 18, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk") today announced the launch of Cypherpunk Mining, which is now the largest Zcash mining fleet in the world, through a $33.33 million equity-based transaction with Winklevoss Capital.

Cypherpunk Technologies Launches World's Largest Zcash Mining Fleet

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026.

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Peer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapy CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Leap Therapeutics, Inc., the biotechnology subsidiary of Cypherpunk Technologies Inc. (Nasdaq: CYPH), today announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research.

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript

Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript

Cypherpunk Technologies Inc. (CYPH) Shareholder/Analyst Call Prepared Remarks Transcript

Cypherpunk Technologies Reports First Quarter 2026 Financial Results

CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026.

Cypherpunk Technologies Reports First Quarter 2026 Financial Results

Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard

CAMBRIDGE, Mass., April 15, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced its latest purchase of 9,163.32 ZEC for $2,150,000 at an average purchase price of $234.63 per ZEC and launched its new website and investor dashboard at cypherpunk.com.

Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard

Cypherpunk Reports Full Year 2025 Financial Results

CAMBRIDGE, Mass., March 16, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the year ended December 31, 2025.

Cypherpunk Reports Full Year 2025 Financial Results

Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)

Cypherpunk expands its holdings with new $5M investment in Zcash company, ZODL, alongside key investors including a16z, Winklevoss Capital, Coinbase, Paradigm, Chapter One, David Friedberg , Balaji Srinivasan, and others CAMBRIDGE, Mass., March 9, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced the company has invested $5M into Zcash Open Development Lab (ZODL) marking its first technology investment outside of ZEC.

Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL)

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt